These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14288457)

  • 21. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Branched chain ketoaciduria (maple syrup urine disease).
    Snyderman SE
    Clin Perinatol; 1976 Mar; 3(1):41-52. PubMed ID: 954344
    [No Abstract]   [Full Text] [Related]  

  • 23. Congenital lactic acidosis, alpha-ketoglutaric aciduria and variant form of maple syrup urine disease due to a single enzyme defect: dihydrolipoyl dehydrogenase deficiency.
    Munnich A; Saudubray JM; Taylor J; Charpentier C; Marsac C; Rocchiccioli F; Amedee-Manesme O; Coude FX; Frezal J; Robinson BH
    Acta Paediatr Scand; 1982 Jan; 71(1):167-71. PubMed ID: 6897145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maple syrup urine disease (branched chain ketoaciduria).
    Harper PA; Healy PJ; Dennis JA
    Am J Pathol; 1990 Jun; 136(6):1445-7. PubMed ID: 2356868
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnosis and treatment of maple syrup disease: a study of 36 patients.
    Morton DH; Strauss KA; Robinson DL; Puffenberger EG; Kelley RI
    Pediatrics; 2002 Jun; 109(6):999-1008. PubMed ID: 12042535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and biochemical observations on an apparently nonfatal variant of branched-chain ketoaciduria (maple syrup urine disease).
    MORRIS MD; LEWIS BD; DOOLAN PD; HARPER HA
    Pediatrics; 1961 Dec; 28():918-23. PubMed ID: 14476272
    [No Abstract]   [Full Text] [Related]  

  • 27. 4,5-dimethyl-3-hydroxy-2[5H]-furanone (sotolone)--the odour of maple syrup urine disease.
    Podebrad F; Heil M; Reichert S; Mosandl A; Sewell AC; Böhles H
    J Inherit Metab Dis; 1999 Apr; 22(2):107-14. PubMed ID: 10234605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The gas-chromatographic diagnosis of intermittent maple syrup urine disease (branch-chain ketoaciduria).
    Gompertz D; Draffan GH
    Clin Chim Acta; 1972 Aug; 40(1):5-11. PubMed ID: 5056643
    [No Abstract]   [Full Text] [Related]  

  • 29. The enzyme defect in maple syrup urine disease (branched chain ketoaciduria).
    Seegmiller JE; Westall RG
    J Ment Defic Res; 1967 Dec; 11(4):288-94. PubMed ID: 5582930
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
    Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MAPLE SYRUP URINE DISEASE.
    SNYDERMAN SE; HOLT LE
    J Maine Med Assoc; 1964 Jan; 55():3-5. PubMed ID: 14109847
    [No Abstract]   [Full Text] [Related]  

  • 32. [On the clinical picture and pathological anatomy of the maple syrup disease ("branded chain ketoaciduria"). Report on 2 cases in 1 family].
    Sander C; Clotten R; Noetzel H; Wehinger H
    Dtsch Med Wochenschr; 1968 May; 93(18):895-903 passim. PubMed ID: 5650843
    [No Abstract]   [Full Text] [Related]  

  • 33. Quantification of branched-chain amino acids in blood spots and plasma by liquid chromatography tandem mass spectrometry for the diagnosis of maple syrup urine disease.
    Sowell J; Pollard L; Wood T
    J Sep Sci; 2011 Mar; 34(6):631-9. PubMed ID: 21328532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An early diagnosis leads to a good prognosis: a patient with maple syrup urine disease--screened by tandem mass spectrometry.
    Lin JF; Chiu PC; Hsu HY; Lin SM; Chen YY; Hsieh KS
    Acta Paediatr Taiwan; 2004; 45(5):287-9. PubMed ID: 15868812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-body L-leucine oxidation in patients with variant form of maple syrup urine disease.
    Schadewaldt P; Bodner-Leidecker A; Hammen HW; Wendel U
    Pediatr Res; 2001 May; 49(5):627-35. PubMed ID: 11328944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease.
    Snyderman SE; Goldstein F; Sansaricq C; Norton PM
    Pediatr Res; 1984 Sep; 18(9):851-3. PubMed ID: 6483508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synaptic plasma membrane Na(+), K (+)-ATPase activity is significantly reduced by the alpha-keto acids accumulating in maple syrup urine disease in rat cerebral cortex.
    Wajner A; Bürger C; Dutra-Filho CS; Wajner M; de Souza Wyse AT; Wannmacher CM
    Metab Brain Dis; 2007 Mar; 22(1):77-88. PubMed ID: 17295076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolongation of G1 and S phase in C-6 glioma cells treated with maple syrup urine disease metabolits. Morphologic and cell cycle studies.
    Liao CL; Herman MM; Bensch KG
    Lab Invest; 1978 Feb; 38(2):122-33. PubMed ID: 564423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful pregnancy in maple syrup urine disease: a case report and review of the literature.
    Grünert SC; Rosenbaum-Fabian S; Schumann A; Schwab KO; Mingirulli N; Spiekerkoetter U
    Nutr J; 2018 May; 17(1):51. PubMed ID: 29753318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermittent branched-chain ketonuria. Variant of maple-syrup-urine disease.
    Dancis J; Hutzler J; Rokkones T
    N Engl J Med; 1967 Jan; 276(2):84-9. PubMed ID: 6015521
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.